{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:24:28Z","timestamp":1788899068914,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006560","name":"Yildiz Technical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bioadv.2024.213862","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T03:15:42Z","timestamp":1713237342000},"page":"213862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Targeted delivery of rifaximin using P6.2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections"],"prefix":"10.1016","volume":"161","author":[{"given":"Pelin Pelit","family":"Arayici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Coksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2024.213862_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.btre.2020.e00427","article-title":"Green synthesis of metallic nanoparticles as effective alternatives to treat antibiotics resistant bacterial infections: a review","volume":"25","author":"Singh","year":"2020","journal-title":"Biotechnology Reports"},{"issue":"2","key":"10.1016\/j.bioadv.2024.213862_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2471\/BLT.17.199687","article-title":"Complex determinants of inappropriate use of antibiotics","volume":"96","author":"Tangcharoensathien","year":"2018","journal-title":"Bull. World Health Organ."},{"issue":"5","key":"10.1016\/j.bioadv.2024.213862_bb0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ijms17050603","article-title":"Antimicrobial peptides as potential alternatives to antibiotics in food animal industry","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bioadv.2024.213862_bb0020","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/ijms20071781","article-title":"Two component regulatory systems and antibiotic resistance in gram-negative pathogens","volume":"20","author":"Bhagirath","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213862_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.idc.2016.02.001","article-title":"Overview: global and local impact of antibiotic resistance","volume":"30","author":"Watkins","year":"2016","journal-title":"Infect. Dis. Clin."},{"issue":"70","key":"10.1016\/j.bioadv.2024.213862_bb0030","doi-asserted-by":"crossref","first-page":"16644","DOI":"10.1002\/chem.202003821","article-title":"Green algae as a drug delivery system for the controlled release of antibiotics","volume":"26","author":"Shchelik","year":"2020","journal-title":"Chemistry\u2013A European Journal"},{"key":"10.1016\/j.bioadv.2024.213862_bb0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1208\/s12249-013-9949-x","article-title":"Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin","volume":"14","author":"Karanje","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2024.213862_bb0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ijbiomac.2021.05.022","article-title":"Synthesis of rifaximin loaded chitosan-alginate core-shell nano- particles (Rif@ CS\/Alg-NPs) for antibacterial applications","volume":"183","author":"Kumar","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213862_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.22456\/2527-2616.98376","article-title":"Eco-friendly and miniaturized analytical method for quantification of rifaximin in tablets","volume":"3","author":"Motta","year":"2019","journal-title":"Drug Analytical Research"},{"key":"10.1016\/j.bioadv.2024.213862_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1329-8","article-title":"Submission of rifaximin to different techniques: characterization, solubility study, and microbiological evaluation","volume":"20","author":"Kogawa","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","article-title":"Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases","volume":"26","author":"Koo","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.bioadv.2024.213862_bb0060","series-title":"Mayo Clinic Proceedings","article-title":"Therapeutic effects and mechanisms of action of rifaximin in gastrointestinal diseases","author":"DuPont","year":"2015"},{"key":"10.1016\/j.bioadv.2024.213862_bb0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fcimb.2019.00044","article-title":"Rifaximin alters intestinal microbiota and prevents progression of ankylosing spondylitis in mice","volume":"9","author":"Yang","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioadv.2024.213862_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116782","article-title":"Designing, structural determination and biological effects of rifaximin loaded chitosan-carboxymethyl chitosan nanogel","volume":"248","author":"Algharib","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2024.213862_bb0075","author":"Cayman Chemical"},{"key":"10.1016\/j.bioadv.2024.213862_bb0080","unstructured":"Aypak, S.\u00dc. and \u0130. Asl\u0131han, BA\u015eARISIZ TEDAV\u0130N\u0130N OLASI SORUMLUSU: P GL\u0130KOPROTE\u0130NLER Reason for the Ineffective Treatment: P Glycoproteins. Bozok T\u0131p Dergisi. 7(3): p. 81\u201388."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1872213X10666161230111226","article-title":"Rifaximin-chitosan nanoparticles for inflammatory bowel disease (IBD)","volume":"11","author":"Kumar","year":"2017","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"issue":"4","key":"10.1016\/j.bioadv.2024.213862_bb0090","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/acs.molpharmaceut.0c01022","article-title":"Elucidating the Molecular Mechanism of Drug\u2013Polymer Interplay in a Polymeric Supersaturated System of Rifaximin","volume":"18","author":"Singh","year":"2021","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bioadv.2024.213862_bb0095","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1128\/AAC.01108-07","article-title":"Systemic pharmacokinetics of rifaximin in volunteers with shigellosis","volume":"52","author":"Taylor","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.bioadv.2024.213862_bb0100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ja.2014.106","article-title":"Rifaximin: beyond the traditional antibiotic activity","volume":"67","author":"Calanni","year":"2014","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bioadv.2024.213862_bb0105","doi-asserted-by":"crossref","unstructured":"DuPont, H.L., et al., Antimicrobial susceptibility of Staphylococcus isolates from the skin of patients with diarrhea-predominant irritable bowel syndrome treated with repeat courses of rifaximin. Antimicrobial Agents and Chemotherapy, 2017. 61(1): p. 10.1128\/aac.02165-16.","DOI":"10.1128\/AAC.02165-16"},{"key":"10.1016\/j.bioadv.2024.213862_bb0110","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s11999-015-4300-3","article-title":"Rifamycin derivatives are effective against staphylococcal biofilms in vitro and elutable from PMMA","volume":"473","author":"Sanchez","year":"2015","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"3","key":"10.1016\/j.bioadv.2024.213862_bb0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1570163812666150817113230","article-title":"Ternary inclusion complexes of rifaximin with \u03b2-cyclodextrin and sodium deoxycholate for solubility enhancement","volume":"12","author":"Kaur","year":"2015","journal-title":"Curr. Drug Discov. Technol."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/10717544.2020.1736208","article-title":"Fibroin nanoparticles: a promising drug delivery system","volume":"27","author":"Pham","year":"2020","journal-title":"Drug Deliv."},{"issue":"11","key":"10.1016\/j.bioadv.2024.213862_bb0125","doi-asserted-by":"crossref","first-page":"181457","DOI":"10.1098\/rsos.181457","article-title":"Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy","volume":"5","author":"Wan","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.bioadv.2024.213862_bb0130","doi-asserted-by":"crossref","first-page":"867655","DOI":"10.3389\/fonc.2022.867655","article-title":"Nano-drug delivery systems entrapping natural bioactive compounds for cancer: recent progress and future challenges","volume":"12","author":"Chavda","year":"2022","journal-title":"Front. Oncol."},{"issue":"16","key":"10.1016\/j.bioadv.2024.213862_bb0135","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.3390\/molecules25163760","article-title":"Recent advances in polymeric nanoparticle-encapsulated drugs against intracellular infections","volume":"25","author":"S\u00e1nchez","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bfopcu.2017.01.002","article-title":"Adsorption behavior of some metal ions on nanoparticles used in pharmaceutical matrices: application to laboratory made drug formulation","volume":"55","author":"Ragab","year":"2017","journal-title":"Bulletin of Faculty of Pharmacy, Cairo University"},{"key":"10.1016\/j.bioadv.2024.213862_bb0145","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","author":"Din","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2024.213862_bb0150","doi-asserted-by":"crossref","first-page":"120807","DOI":"10.1016\/j.ijpharm.2021.120807","article-title":"PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up","volume":"605","author":"Operti","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bioadv.2024.213862_bb0155","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1021\/mp400536z","article-title":"Translocator protein ligand\u2013plga conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells","volume":"11","author":"Laquintana","year":"2014","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.bioadv.2024.213862_bb0160","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3109\/10717544.2015.1058433","article-title":"A novel ligand conjugated nanoparticles for oral insulin delivery","volume":"23","author":"Liu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2024.213862_bb0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13204-017-0548-0","article-title":"Nanoparticle targeting of gram-positive and gram-negative bacteria for magnetic-based separations of bacterial pathogens","volume":"7","author":"Lu","year":"2017","journal-title":"Appl. Nanosci."},{"issue":"49","key":"10.1016\/j.bioadv.2024.213862_bb0170","doi-asserted-by":"crossref","first-page":"1903296","DOI":"10.1002\/smll.201903296","article-title":"pH-responsive PEG-shedding and Targeting peptide-modified nano- particles for dual-delivery of irinotecan and microRNA to enhance tumor-specific therapy","volume":"15","author":"Juang","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2024.213862_bb0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.colsurfb.2014.02.026","article-title":"Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel","volume":"117","author":"Kulhari","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bioadv.2024.213862_bb0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fchem.2017.00122","article-title":"Cationic antimicrobial peptides inactivate Shiga toxin-encoding bacteriophages","volume":"5","author":"Del Cogliano","year":"2017","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioadv.2024.213862_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103886","article-title":"Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6. 2","volume":"139","author":"Mart\u00ednez","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioadv.2024.213862_bb0190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.colsurfb.2017.02.003","article-title":"Lipid selectivity in novel antimicrobial peptides: implication on antimicrobial and hemolytic activity","volume":"153","author":"Maturana","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.bioadv.2024.213862_bb0195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5650\/jos.ess20299","article-title":"Effects of polyvinyl alcohol on drug release from nanocomposite particles using poly (L-lactide-co-glycolide)","volume":"70","author":"Takeuchi","year":"2021","journal-title":"J. Oleo Sci."},{"issue":"6","key":"10.1016\/j.bioadv.2024.213862_bb0200","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/10837450.2020.1740933","article-title":"Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells","volume":"25","author":"Ersoz","year":"2020","journal-title":"Pharm. Dev. Technol."},{"issue":"S1","key":"10.1016\/j.bioadv.2024.213862_bb0205","doi-asserted-by":"crossref","first-page":"E486","DOI":"10.1002\/adv.21295","article-title":"Optimizing the process parameters for encapsulation of linamarin into PLGA nanoparticles using double emulsion solvent evaporation technique","volume":"32","author":"Hussein","year":"2013","journal-title":"Adv. Polym. Technol."},{"key":"10.1016\/j.bioadv.2024.213862_bb0210","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/341848","article-title":"Caffeic acid phenethyl ester loaded PLGA nanoparticles: effect of various process parameters on reaction yield, encapsulation efficiency, and particle size","volume":"2015","author":"Derman","year":"2015","journal-title":"J. Nanomater."},{"issue":"4","key":"10.1016\/j.bioadv.2024.213862_bb0215","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1515\/tjb-2015-0014","article-title":"Particle size and zeta potential investigation of synthetic peptide-protein conjugates\/Sentetik peptid-protein konjugatlar\u0131n\u0131n par\u00e7ac\u0131k boyutu ve zeta potensiyel analizi","volume":"40","author":"Derman","year":"2015","journal-title":"Turkish Journal of Biochemistry"},{"key":"10.1016\/j.bioadv.2024.213862_bb0220","series-title":"Colloids and Surfaces B: Biointerfaces","first-page":"113421","article-title":"Effect of Polycation Coating on the Long-Term Pulsatile Release of Antigenic ESAT-61-20 Peptide from PLGA Nanoparticles","author":"B\u00fcy\u00fckbayraktar","year":"2023"},{"issue":"11","key":"10.1016\/j.bioadv.2024.213862_bb0225","doi-asserted-by":"crossref","first-page":"115702","DOI":"10.1088\/1361-6528\/ad1444","article-title":"Ketoconazole-loading strategy to improve antifungal activity and overcome cytotoxicity on human renal proximal tubular epithelial cells","volume":"35","author":"Coksu","year":"2023","journal-title":"Nanotechnology"},{"issue":"48","key":"10.1016\/j.bioadv.2024.213862_bb0230","doi-asserted-by":"crossref","first-page":"485601","DOI":"10.1088\/1361-6528\/ac1c22","article-title":"A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2","volume":"32","author":"Ucar","year":"2021","journal-title":"Nanotechnology"},{"issue":"32","key":"10.1016\/j.bioadv.2024.213862_bb0235","doi-asserted-by":"crossref","first-page":"9483","DOI":"10.1002\/slct.201901375","article-title":"Rabies virus 31D peptide-[P (VP-co-AA)] conjugates: synthesis, characterization and cytotoxicity evaluation","volume":"4","author":"Arayici","year":"2019","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2008-2231-21-58","article-title":"Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel","volume":"21","author":"Manoochehri","year":"2013","journal-title":"DARU Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0245","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1038\/s41598-022-14997-y","article-title":"Environmentally azithromycin pharmaceutical wastewater management and synergetic biocompatible approaches of loaded azithromycin@ hematite nanoparticles","volume":"12","author":"Al-Hakkani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2024.213862_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.surfin.2022.101877","article-title":"Cefixime wastewater management via bioengineered hematite nanoparticles and the in-vitro synergetic potential multifunction activities of Cefixime@ hematite nanosystem","volume":"30","author":"Al-Hakkani","year":"2022","journal-title":"Surfaces and Interfaces"},{"key":"10.1016\/j.bioadv.2024.213862_bb0255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2023.06.001","article-title":"Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability","volume":"359","author":"Lu","year":"2023","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.bioadv.2024.213862_bb0260","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10989-018-9753-2","article-title":"Development of vaccine prototype against Zika virus disease of peptide-loaded PLGA nanoparticles and evaluation of cytotoxicity","volume":"25","author":"\u00c7alman","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213862_bb0265","first-page":"90","article-title":"A new strategy to achieve high antimicrobial activity: green synthesised silver nanoparticle formulations with and","volume":"74","author":"Ozdemir","year":"2023","journal-title":"Arch. Ind. Hyg. Toxicol."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213862_bb0270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/0929866530666221202123011","article-title":"A temporin derived peptide showing antibacterial and antibiofilm activities against Staphylococcus aureus","volume":"30","author":"An","year":"2023","journal-title":"Protein Pept. Lett."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213862_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3314","article-title":"Design of a bactericidal hydrogel scaffold containing genipin crosslinked HF-18 peptide","volume":"39","author":"Boncukcu","year":"2023","journal-title":"Biotechnol. Prog."},{"issue":"2\u20133","key":"10.1016\/j.bioadv.2024.213862_bb0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jconrel.2005.08.013","article-title":"Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin","volume":"108","author":"Mo","year":"2005","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0285","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1038\/s41598-022-14922-3","article-title":"Cefotaxime removal enhancement via bio-nanophotocatalyst \u03b1-Fe2O3 using photocatalytic degradation technique and its echo-biomedical applications","volume":"12","author":"Al-Hakkani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2024.213862_bb0290","first-page":"5355","article-title":"Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties","author":"Betbeder","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.bioadv.2024.213862_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061416","article-title":"Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis","volume":"8","author":"Chaowanachan","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bioadv.2024.213862_bb0300","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/jps.21158","article-title":"PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug","volume":"97","author":"Sahana","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2024.213862_bb0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11051-023-05672-y","article-title":"Chitosan\/tripolyphosphate nanoparticle as elastase inhibitory peptide carrier: characterization and its in vitro release study","volume":"25","author":"Xiong","year":"2023","journal-title":"J. Nanopart. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0310","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.colsurfb.2009.08.043","article-title":"Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemo- therapeutic and thermo-optical agents","volume":"75","author":"Manchanda","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"5","key":"10.1016\/j.bioadv.2024.213862_bb0315","doi-asserted-by":"crossref","first-page":"712","DOI":"10.5603\/RPOR.a2021.0100","article-title":"Therapeutic efficacy of rifaximin loaded tamarind gum polysaccharide nanoparticles in TNBS induced IBD model Wistar rats","volume":"26","author":"Amaldoss","year":"2021","journal-title":"reports of practical Oncology and radiotherapy"},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0320","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/21691401.2018.1556213","article-title":"Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells","volume":"47","author":"Ersoz","year":"2019","journal-title":"Artificial cells, nanomedicine, and biotechnology"},{"key":"10.1016\/j.bioadv.2024.213862_bb0325","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10096-008-0602-7","article-title":"Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?","volume":"28","author":"Acton","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bioadv.2024.213862_bb0330","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/jam.13601","article-title":"Synthesis, characterization and antibacterial activity of juglone encapsulated PLGA nanoparticles","volume":"123","author":"Arasoglu","year":"2017","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.bioadv.2024.213862_bb0335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3906\/biy-1604-80","article-title":"Preparation, characterization, and enhanced antimicrobial activity: quercetin-loaded PLGA nanoparticles against foodborne pathogens","volume":"41","author":"Araso\u011flu","year":"2017","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.bioadv.2024.213862_bb0340","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3469525","article-title":"Cytotoxicity evaluation of endodontic pins on L929 cell line","volume":"2019","author":"Cannella","year":"2019","journal-title":"Biomed. Res. Int."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950824001055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950824001055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T20:01:25Z","timestamp":1717444885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950824001055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":68,"alternative-id":["S2772950824001055"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.213862","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted delivery of rifaximin using P6.2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.213862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"213862"}}